Diagnosis and therapy of weakly/non-acidic gastroesophageal reflux disease;Aktuelle diagnostik und therapie der schwach sauren/nicht sauren gastroösophagealen refluxkrankheit

Deutsche Medizinische Wochenschrift

Volumn 130, Issue 40, 2005, Pages 2266-2269

  Meining, A ^a,b   Bajbouj, M ^a   Stein, H J ^b   Schmid, R M ^a  

^a II Medizinische Klinik und Poliklinik   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; BACLOFEN;

DIAGNOSTIC PROCEDURE; ENDOSCOPY; GASTROESOPHAGEAL REFLUX; HUMAN; HYPERGASTRINEMIA; MANOMETRY; REVIEW; STOMACH FUNDOPLICATION; TECHNIQUE;

BACLOFEN; ELECTRIC IMPEDANCE; ESOPHAGOSCOPY; ESOPHAGUS; FUNDOPLICATION; GABA AGONISTS; GASTROESOPHAGEAL REFLUX; HUMANS; HYDROGEN-ION CONCENTRATION; MANOMETRY; PROTON PUMPS;

EID: 27144508178     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-918561     Document Type: Review

References (16)

1. Guillemot F, Ducrotte P, Bueno L. Prevalence of functional gastrointestinal disorders in a population of subjects consulting for gastroesophageal reflux disease in general practice. Gastroenterol Clin Biol 2005; 29: 243-246
2. Kawano S, Murata H, Tsuji S et al. Randomized comparative study of omeprazole and famotidine in reflux esophagitis. J Gastroenterol Hepatol 2002; 17: 955-959
3. Koek GH, Sifrim D, Lerut T, Janssens J, Tack J. Effect of the GABA(B) agonist baclofen in patients with symptoms and duodeno-gastro-oesophageal reflux refractory to proton pump inhibitors. Gut 2003; 52: 1397-1402
4. Locke GR, Talley NJ, Fett SL et al. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology 1997; 112: 1448-1456
5. Mainie I, Tutuian R, Agrawal A, Hila A, Freeman J, Castell D. Reflux (acid or non-acid) detected by multichannel intraluminal impedance-pH testing predicts good symptom response from fundoplication. Gastroenterol 2005; 128: A1-826(Suppl 2
6. Meining A, Fackler A, Tzavella K et al. Lower esophageal sphincter pressure in patients with gastroesophageal reflux diseases and posture and time patterns. Dis Esophagus 2004; 17: 155-158
7. Menges M, Muller M, Zeitz M. Increased acid and bile reflux in Barrett's esophagus compared to reflux esophagitis, and effect of proton pump inhibitor therapy. Am J Gastroenterol 2001; 96: 331-337
8. Milkes D, Gerson LB, Triadafilopoulos G. Complete elimination of reflux symptoms does not guarantee normalization of intraesophageal and intragastric pH in patients with gastroesophageal reflux disease (GERD). Am J Gastroenterol 2004; 99: 991-996
9. Nilsson M, Johnsen R, Ye W, Hveem K, Lagergren J. Prevalence of gastro-oesophageal reflux symptoms and the influence of age and sex. Scand J Gastroenterol 2004; 39: 1040-1045
10. Quigley EM. Non-erosive reflux disease: part of the spectrum of gastro-oesophageal reflux disease, a component of functional dyspepsia, or both? Eur J Gastroenterol Hepatol 2001; 13: S13-18(Suppl 1
11. van Rensburg CJ, Bardhan KD. No clinical benefit of adding cisapride to pantoprazole for treatment of gastro-oesophageal reflux disease. Eur J Gastroenterol Hepatol 2001; 13: 909-914
12. Sifrim D, Castell D, Dent J, Kahrilas PJ. Gastro-oesophageal reflux monitoring: review and consensus report on detection and definitions of acid, non-acid, and gas reflux. Gut 2004; 53: 1024-1031
13. Soga T, Matsuura M, Kodama Y et al. Is a proton pump inhibitor necessary for the treatment of lower-grade reflux esophagitis? J Gastroenterol 1999; 34: 435-440
14. Stein HJ, Feussner H, Siewert JR. Indikation zur Antirefluxchirurgie des Oesophagus. Chirurg 1998; 69: 132-140
15. Vaezi MF, Richter JE. Importance of duodeno-gastro-esophageal reflux in the medical outpatient practice. Hepatogastroenterology 1999; 46: 40-47
16. Vakil NB, Traxler B, Levine D. Dysphagia in patients with erosive esophagitis: prevalence, severity, and response to proton pump inhibitor treatment. Clin Gastroenterol Hepatol 2004; 2: 665-668